Philadelphia, 17 - 18 September 2024
Schedule
Create your personal agenda –check the favourite icon
Sep 178:50
Conference pass
Introductory remarks
Keynotes
Anna Abiola, Producer, Terrapinn Holdings Ltd
Sep 178:55
Conference pass
Chair remarks
Keynotes
Ziv BarJoseph, Head, R&D Data and Computational Sciences, Sanofi
Sep 179:00
Conference pass
Keynote presentation
Keynotes
Hal Stern, VP & CIO, Pharmaceutical R&D, Janssen
Sep 1710:00
Conference pass
Unlocking Future Innovation: Harnessing Data Analytics and Digital Technology as the Cornerstones
Keynotes
Moderator: Victoria Gamerman, Head of Digital Transformation Center of Excellence, Boehringer Ingelheim
Sep 1711:40
Conference pass
Chair remarks
AI in Drug Discovery and Development
Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Sep 1711:40
Conference pass
Chair remarks
Digital Transformation
Katie Baca-Motes, Chief Strategy Officer, CareEvolution
Sep 1711:40
Conference pass
Chair remarks
Big Data in Oncology
Samir Hanash, Director, Red And Charline Mccombs Institute For The Early Detection And Treatment Of Cancer, MD Anderson Cancer Center
Sep 1711:40
Conference pass
Chair remarks
Data Integration + FAIR
Jennifer Heymont, Associate Director, Scientific Informatics, Eisai Inc
Sep 1711:40
Conference pass
Sep 1711:40
Conference pass
Chair remarks
Real World Evidence
Solomon Makgoeng, Director, Department of Epidemiology, Pfizer
Sep 1711:40
Conference pass
Chair remarks
Gene Therapy
Dimitri Talantov, Head of Immunology Early Development Operations, Janssen R&D
Sep 1711:40
Conference pass
Chair remarks
Biomarkers and Companion Diagnostics
Ravinder Singh, Director Endocrine Laboratoies, Mayo Clinic
Sep 1711:40
Conference pass
Chair remarks
Biomarkers and Companion Diagnostics
Ravinder Singh, Director Endocrine Laboratoies, Mayo Clinic
Sep 1711:45
Conference pass
Data driven drug discovery: The AbbVie perspective
AI in Drug Discovery and Development
Abhishek Pandey, Global Lead and Principal Research Scientist, Abbvie
Sep 1711:45
Conference pass
Establishing a Value Framework for building GenAI capabilities
Large Language Models
Alex Villalobos, Operations Excellence and Digital Lead, Boehringer Ingelheim
Sep 1711:45
Conference pass
Mining petabytes of proteomics data for cancer diagnostics and therapeutics
Big Data in Oncology
Samir Hanash, Director, Red And Charline Mccombs Institute For The Early Detection And Treatment Of Cancer, MD Anderson Cancer Center
Sep 1711:45
Conference pass
The Scope of Fair Data
Data Integration + FAIR
Jennifer Heymont, Associate Director, Scientific Informatics, Eisai Inc
Sep 1711:45
Conference pass
Biological Data Science to Drive Drug Discovery: Case Studies
Bioinformatics + In Silico R&D
Joseph Szustakowski, Vice President, Translational Bioinformatics, Bristol-Myers Squibb
Sep 1711:45
Conference pass
Optimizing Data Management for Histology and Cellular Imaging Research: Challenges and Opportunities
Data Management, Storage and Architecture
Nevin Gerek Ince, Director, Novo Nordisk
Sep 1711:45
Conference pass
AI Impact on Epidemiology Practice in Pharmaceutical R&D
Real World Evidence
Solomon Makgoeng, Director, Department of Epidemiology, Pfizer
Sep 1711:45
Conference pass
In vivo correction of human phenylketonuria variants via prime editing and base editing
Gene Therapy
Xiao Wang, Research Assistant Professor, Univeristy Of Pennsylvania
Sep 1711:45
Conference pass
Biomarker Capture and Analysis for Diagnosis and Therapeutic Intervention
Biomarkers and Companion Diagnostics
Vaibhav Saini, Sr. Commercialization Manager, Northeastern University
Sep 1712:25
Conference pass
Digital Twins in Drug Discovery and Development
AI in Drug Discovery and Development
Tiffany Fabianac, Enterprise Data and AI Engagement Lead, AstraZeneca
Sep 1712:25
Conference pass
Using knowledge to improve LLM performance and outcomes
Large Language Models
Sep 1712:25
Conference pass
Shaping the regulatory function to support product digital transformation
Digital Transformation
David Morra, Director, Regulatory Digital Health, Merck
Sep 1712:25
Conference pass
Implementation of real world multi-model data in oncology discovery and development
Big Data in Oncology
Sunita Badola, Head, Oncology Data Strategy & Partnerships, Takeda Pharmaceuticals
Sep 1712:25
Conference pass
What is FAIR in Data Integration
Data Integration + FAIR
Alexander Sherman, Director, Center for innovation and Bioinformatics Neurological Clinical Research, Massachusetts General Hospital
Sep 1712:25
Conference pass
Preparing for pervasive AI – ontologies, data lakes and governance
Bioinformatics + In Silico R&D
Sep 1712:25
Conference pass
Real world evidence on digital health in diabetes
Real World Evidence
Felix Lee, US Digital Healthcare Medical Head, Sanofi
Sep 1712:25
Conference pass
Reinventing Clinical Trial Models: Promises and Challenges
Gene Therapy
Dimitri Talantov, Head of Immunology Early Development Operations, Janssen R&D
Sep 1712:25
Conference pass
Companion Diagnostics - start with the end in mind
Biomarkers and Companion Diagnostics
Lee-anne Zinetti, Senior Director, Global Lead Precision Medicine, Novartis
Sep 1713:05
Conference pass
Robustness in AI
AI in Drug Discovery and Development
Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Sep 1713:05
Conference pass
Fantastic Large Language Models (LLMs) and How to Optimize Them
Large Language Models
Shams Zaman, Senior Director, Global Biometrics & Data Sciences, Bristol-Myers Squibb
Sep 1713:05
Conference pass
Making Digital Transformation a Success: Technology, Strategy and People
Digital Transformation
Waheed Jowiya, Digitalisation Strategy Lead, Novo Nordisk
Sep 1713:05
Conference pass
Insights from internal and external oncology data toward successful study designs – leveraging AI/NLP
Big Data in Oncology
Harpreet Sahni, Director and Strategic Lead Information Practice, Late Stage Oncology, AstraZeneca
Sep 1713:05
Conference pass
Utilizing large-scale biobank-based human circulating proteomics and genetics to enhance novel therapeutic target discovery
Bioinformatics + In Silico R&D
Yi-Hsiang Hsu, Director and associate Professor, Broad Institute of MIT and Harvard
Sep 1713:05
Conference pass
Real World Evidence in pharmacovigilance
Real World Evidence
William Blumentals, Head of Pharmacoepidemiology, Specialty Care, Sanofi
Sep 1713:05
Conference pass
How to pay for gene therapy
Gene Therapy
Joseph Fuhr, Adjunct Faculty, Johns Hopkins University
Sep 1713:05
Conference pass
How to pay for gene therapy
Gene Therapy
Joseph Fuhr, Adjunct Faculty, Johns Hopkins University
Sep 1713:05
Conference pass
FDA and the evolution of companion diagnostics
Biomarkers and Companion Diagnostics
Ravinder Singh, Director Endocrine Laboratoies, Mayo Clinic
Sep 1714:25
Conference pass
Chair remarks
AI in Drug Discovery and Development
Gregory Fiore, Former CEO, Exacis Biotherapeutics
Sep 1714:25
Conference pass
Chair remarks
Data Integration + FAIR
Jennifer Heymont, Associate Director, Scientific Informatics, Eisai Inc
Sep 1714:25
Conference pass
Chair remarks
Data Management, Storage and Architecture
Sep 1714:25
Conference pass
Chair remarks
Real World Evidence
Kristy Singletary, Director, L&D Strategy Lead, Enabling Functions, Pfizer
Sep 1714:25
Conference pass
Chair remarks
Gene Therapy
Dimitri Talantov, Head of Immunology Early Development Operations, Janssen R&D
Sep 1714:25
Conference pass
Chair remarks
Biomarkers and Companion Diagnostics
Ravinder Singh, Director Endocrine Laboratoies, Mayo Clinic
Sep 1714:30
Conference pass
Multiomics and deep machine learning in IBD patient subtyping
AI in Drug Discovery and Development
Dimitra Chalkia, VP Computational Biology, Athos Therapeutics Inc
Sep 1714:30
Conference pass
Different use cases of Large Language Models for improving clinical trials
Large Language Models
Amir Emadzadeh, Director, Software Engineering, Genentech
Sep 1714:30
Conference pass
Bringing the digital world into a manufacturing facility
Digital Transformation
Britta Stager, Senior Technology Associate, MSAT, GSK
Sep 1714:30
Conference pass
Oncology biobanks: Partners in research for quality patient samples and data
Big Data in Oncology
Dianne Chadwick, Associate Director, Ontario Tumour and Data Repository
Sep 1714:30
Conference pass
Speaker presentation
Data Integration + FAIR
Daniel Kircher, Manager, IT Business Partner, Early Phase Translational Medicine, Otsuka
Sep 1714:30
Conference pass
Neoantigen Cancer Vaccine Delivery
Bioinformatics + In Silico R&D
Don Diamond, Professor, Department Of Hematology And Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center
Sep 1714:30
Conference pass
Design and AI
Data Management, Storage and Architecture
Sep 1714:30
Conference pass
Creating an environment for psychological safety to drive innovation
Real World Evidence
Kristy Singletary, Director, L&D Strategy Lead, Enabling Functions, Pfizer
Sep 1714:30
Conference pass
New-born Screening in Gene Therapy
Gene Therapy
Tara Britt, President & Founder, Rare Disease Innovations Institute, Inc.
Sep 1714:30
Conference pass
Foundation models in the search for new patients segments and biomarker discovery
Biomarkers and Companion Diagnostics
Etai Jacob, Senior Director, Head of Data Science and AI, Early Oncology, AstraZeneca
Sep 1715:10
Conference pass
Leveraging Epidemiology, AI/ ML and RWD to discover new indications
AI in Drug Discovery and Development
Leo Russo, Vice President and Head of Global Medical Epidemiolog, Pfizer
Sep 1715:10
Conference pass
Digital transformation is not just digital optimisation. It‘s about people, processes and technology
Digital Transformation
Sep 1715:10
Conference pass
Using Large data bases to improve decision making for planning and end point
Big Data in Oncology
Natasha Sahr, Director of Biostatistics, Larimar Therapeutics
Sep 1715:10
Conference pass
Clinical trial data pipeline
Data Integration + FAIR
Sep 1715:10
Conference pass
Standardizing and Automating Clinical Exploratory Data: Unveiling Challenges, Sustaining Initiatives, and Long-term Solutions
Data Management, Storage and Architecture
Yuan Tian, Associate Director, Clinical Bioinformatics and Exploratory Analytics, gilead
Sep 1715:10
Conference pass
The Responsibility of Patient Inclusion by all stakeholders
Real World Evidence
Dawn Ireland, President & Founder, CDH International
Sep 1715:10
Conference pass
Planning smooth growth from garage space to pre-clinical studies
Gene Therapy
Scott Dooley, Director, Intellectual Capital, Interius Biotherapeutics
Sep 1715:10
Conference pass
Novel ways for biomarkers using LLM’s
Biomarkers and Companion Diagnostics
Ioannis Kagiampakis, Portfolio Data Science Lead, AstraZeneca
Sep 1715:50
Conference pass
Center for Data-Driven Drug Development and Treatment Assessment (DATA): A National Center to Promote AI for Drug Design and Assessment
AI in Drug Discovery and Development
Kayvan Najarian, Director DATA IUCRC, University of Michigan
Sep 1715:50
Conference pass
Implementing GenAI at enterprise scale for life sciences Industry
Large Language Models
Sairam Menon, Engineering Manager, AI product line owner, Global Pharma R&D Tech, Janssen
Sep 1715:50
Conference pass
Digital transformation in Aggregate Reporting
Digital Transformation
Sep 1715:50
Conference pass
Multi model characterization of advanced malignancies
Big Data in Oncology
Sep 1715:50
Conference pass
Pitfalls and Best Practices: Notes from the (research) field
Data Integration + FAIR
Sep 1715:50
Conference pass
Data Frameworks for Target Discovery
Bioinformatics + In Silico R&D
Sep 1715:50
Conference pass
Solving for the rare disease patient diagnostic odyssey: AI/ML
Real World Evidence
Paul Howard, PhD, Senior Director of Public Policy, Amicus Therapeutics
Sep 1715:50
Conference pass
Developing targeted therapeutic delivery devices for ocular gene therapy
Gene Therapy
Justin Creel, Head Targeted Therapeutics Delivery Center, Novartis
Sep 1715:50
Conference pass
Clavulanic acid decreases cocaine craving- treatment for cocaine addiction
Biomarkers and Companion Diagnostics
Mary Morrison, Vice Chair of Research and Professor of Psychiatry, Lewis Katz School of Medicine, Temple University
Sep 1716:40
Conference pass
Chair remarks
AI in Drug Discovery and Development
Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Sep 1716:40
Conference pass
Chair remarks
Large Language Models
Diane Wuest, VP, AI & Analytics Products, Genmab
Sep 1716:40
Conference pass
Chair remarks
Digital Transformation
Soo Son, Health Equity Advocate, Unlocking Eve
Sep 1716:40
Conference pass
Chair remarks
Big Data in Oncology
Shahed Iqbal, Executive Director and Head, Molecular Epidemiology, Biomarker Sciences, Gilead Sciences
Sep 1716:40
Conference pass
Chair remarks
Data Integration + FAIR
Jennifer Heymont, Associate Director, Scientific Informatics, Eisai Inc
Sep 1716:40
Conference pass
Chair remarks
Bioinformatics + In Silico R&D
Emmanouil Dermitzakis, Vice President and Head of Computational Biology, GSK
Sep 1716:40
Conference pass
Chair remarks
Data Management, Storage and Architecture
Sep 1716:40
Conference pass
Sep 1716:40
Conference pass
Chair remarks
Gene Therapy
Dimitri Talantov, Head of Immunology Early Development Operations, Janssen R&D
Sep 1716:40
Conference pass
Chair remarks
Biomarkers and Companion Diagnostics
Akash Jain, Associate Director, Merck
Sep 1716:45
Conference pass
Leveraging AI for Healthcare Delivery & Insights
AI in Drug Discovery and Development
Sep 1716:45
Conference pass
Speaker presentation
Large Language Models
Shams Zaman, Senior Director, Global Biometrics & Data Sciences, Bristol-Myers Squibb
Sep 1716:45
Conference pass
Overcoming data bias for wellbeing
Digital Transformation
Soo Son, Health Equity Advocate, Unlocking Eve
Sep 1716:45
Conference pass
Clinicogenomic patient level data in drug discovery and translational science
Big Data in Oncology
Paola Correa, Bioinformatics Specialist, Gilead Sciences
Shahed Iqbal, Executive Director and Head, Molecular Epidemiology, Biomarker Sciences, Gilead Sciences
Sep 1716:45
Conference pass
Capturing data models across R&D opperations at a early biotech level
Data Integration + FAIR
Pavan Patel, Senior Scientist, Interius BioTherapeutics, Inc.
Sep 1716:45
Conference pass
Human genomics in drug discovery
Bioinformatics + In Silico R&D
Emmanouil Dermitzakis, Vice President and Head of Computational Biology, GSK
Sep 1716:45
Conference pass
Global ELN Consolidation and Searchability
Data Management, Storage and Architecture
David Deng, Technology Lead, R&D Technology, Data Sciences Institute, Takeda Pharmaceuticals
Sep 1716:45
Conference pass
Using real world evidence in clinical trial data for indication finding
Real World Evidence
Ziv BarJoseph, Head, R&D Data and Computational Sciences, Sanofi
Sep 1716:45
Conference pass
Navigating the Gene Therapy Commercialization Journey
Gene Therapy
Yaa Bruce, Advisor, SPARK at Stanford
Sep 1717:25
Conference pass
"promise vs. hype" and how LLMs will become a standard tool used by all scientists to accelerate and even derisk their work
Large Language Models
Moderator: Aaron Mackey, VP, Head of Data & AI/ML, Sonata Therapeutics
Abhishek Pandey, Global Lead and Principal Research Scientist, Abbvie
Linn Bieske, MIT Leaders For Global Operations, Harvard John A. Paulson School of Engineering and Applied Sciences
Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Flora Nanda, Director AI/ML, Data, Advanced Analytics, Pfizer
Sep 1717:25
Conference pass
Navigating the Digital Frontier: R&D’s Path Ahead
Digital Transformation
Victoria Gamerman, Head of Digital Transformation Center of Excellence, Boehringer Ingelheim
Sep 1717:25
Conference pass
Clinicogenomic patient level data in drug discovery and translational science
Big Data in Oncology
Moderator: Shahed Iqbal, Executive Director and Head, Molecular Epidemiology, Biomarker Sciences, Gilead Sciences
Sunita Badola, Head, Oncology Data Strategy & Partnerships, Takeda Pharmaceuticals
Gaurav Kumar, Associate Director, Genomics and Computational Biology, Teva Pharmaceuticals
Sep 1717:25
Conference pass
Demystifying FAIR
Data Integration + FAIR
Moderator: Jennifer Lee Jennifer Lee, Senior Vice President, Novita Pharmaceuticals
Sudheer Elapavuluru, Principal Agile Coach - Global R&D and Development Strategies, Boehringer Ingelheim
Marc Dencker, Director of Enterprise Architecture & Strategy, Vertex Pharmaceuticals
Alex Villalobos, Operations Excellence and Digital Lead, Boehringer Ingelheim
Sep 1717:25
Conference pass
Leveraging new technologies to support bioinformatics in drug discovery
Bioinformatics + In Silico R&D
William Godinez, Senior Principal Data Scientist, Novartis
Jake Chen, Professor and Chief Bioinformatics Officer, University of Alabama at Birmingham
Sep 1717:25
Conference pass
Challenges in global systems implementation and integration
Data Management, Storage and Architecture
Moderator: David Deng, Technology Lead, R&D Technology, Data Sciences Institute, Takeda Pharmaceuticals
Sep 1717:25
Conference pass
How real is real world data for diversity, equity, inclusion and accessibility?
Real World Evidence
Moderator: Leonie Misquitta, Senior Health Scientist, Office Of The National Coordinator For Health Information Technology
Donna Sattler, Director, Clinical Data Standards, Bristol Myers Squibb
Xiaoying Wu, VP, Data Science Solutions, Privacy & Ethics, R&D, Johnson & Johnson Innovation
Neena Nizar, President and Founder, The Jansens Foundation
Dawn Ireland, President & Founder, CDH International
Sep 1717:25
Conference pass
Development of Gene Therapies: Strategic, Scientific, Regulatory, and Access Considerations
Gene Therapy
Moderator: Alex Sverdlov, Senior Director of Biostatistics, Novartis
Donald Milton, Chief Executive Officer, La Jolla Labs
Dimitri Talantov, Head of Immunology Early Development Operations, Janssen R&D
Sep 1717:25
Conference pass
Biomarkers for Neurodegenerative disease and cancers
Biomarkers and Companion Diagnostics
Mary Morrison, Vice Chair of Research and Professor of Psychiatry, Lewis Katz School of Medicine, Temple University
Raluca Predoiu, Companion Diagnostic Strategy Lead, Abbvie
Create your personal agenda –check the favourite icon
Sep 188:50
Conference pass
Introductory remarks
Keynotes
Anna Abiola, Producer, Terrapinn Holdings Ltd
Sep 189:00
Conference pass
Keynote presentation
Keynotes
Sep 189:40
Conference pass
Keynote presentation
Keynotes
Wendy Benson, Chief Strategy and Innovation Officer, Rady Children's Institute for Genomic Medicine
Sep 1811:40
Conference pass
Chair remarks
AI in Drug Discovery and Development
Nikolai Makaranka, Director, Manufacturing Analytics, Bristol Myers Squibb
Sep 1811:40
Conference pass
Chair remarks
Large Language Models
Waheed Jowiya, Digitalisation Strategy Lead, Novo Nordisk
Sep 1811:40
Conference pass
Chair remarks
Digital Transformation
Aslam Khan, Head of Product Management - R&D, Takeda Pharmaceuticals
Sep 1811:40
Conference pass
Chair remarks
Data Integration + FAIR
Saritha Kuriakose, Senior Director - Data Representation, Novo Nordisk
Sep 1811:40
Conference pass
Chair remarks
Bioinformatics + In Silico R&D
Aridaman Pandit, Senior Principal Research Scientist (Director), AbbVie
Sep 1811:40
Conference pass
Chair remarks
Real World Evidence
Ipek Ozer-Stillman, Vice President, Global Head, Health Economics, Takeda
Sep 1811:40
Conference pass
Chair remarks
Analytics Platform
Sep 1811:40
Conference pass
Sep 1811:40
Conference pass
Chair remarks
Precision Medicine and Liquid Biopsy
Maha Mehanna, Vice President, Business Development & Portfolio, X-Gen Pharmaceuticals, Inc
Sep 1811:40
Conference pass
Chair remarks
Rare Diseases in Genomics
Catherine Brownstein, Professor, Harvard Medical School
Sep 1811:45
Conference pass
Session Confirmation - BioTechX USA 2024 – 17-18 September – Pennsylvania, Philadelphia
AI in Drug Discovery and Development
Chidinma Ekeh, Global Project Manager, Roche
Sep 1811:45
Conference pass
Integrating large language models in companies
Large Language Models
Kevin Lee, Director of Data Innovation, Karuna
Sep 1811:45
Conference pass
Digital Transformation in the life science industry
Digital Transformation
Viswanath Nittala, IT Product Manager, Development Technology, Takeda Pharmaceuticals, Takeda Pharmaceuticals
Aslam Khan, Head of Product Management - R&D, Takeda Pharmaceuticals
Sep 1811:45
Conference pass
FAIR data for gen AI aspirations
Data Integration + FAIR
Saritha Kuriakose, Senior Director - Data Representation, Novo Nordisk
Sep 1811:45
Conference pass
Multi-omics and AI for target identification and validation
Bioinformatics + In Silico R&D
Aridaman Pandit, Senior Principal Research Scientist (Director), AbbVie
Sep 1811:45
Conference pass
Embedding real-world evidence into clinical-decision-making across BUPA
Real World Evidence
Lucy Hoppe, Head of Clinical Evidence, Bupa
Sep 1811:45
Conference pass
Unveiling Oncology Insights through Multimodal Data Analytics on AWS
Analytics Platform
Hyunjae Ryan Kim, Associate Director, Gilead Sciences
Sep 1811:45
Conference pass
Reproducibility of Quantum Computing results in Pharmacology
Quantum Integration
Sep 1811:45
Conference pass
How we integrate preclinical and clinical data for dose selection in oncology
Precision Medicine and Liquid Biopsy
Suzette Girgis, Vice President, Head of Global Clinical Pharmacology & Pharmacometrics, Jazz Pharmaceuticals
Sep 1811:45
Conference pass
Rare disease discovery at a tertiary hospital
Rare Diseases in Genomics
Catherine Brownstein, Professor, Harvard Medical School
Sep 1812:05
Conference pass
Use of Real-world data and real world evidence in rare disease
Rare Diseases in Genomics
Karin Hoelzer, Director of Policy and Regulatory Affairs, National Organization for Rare Disorders
Sep 1812:25
Conference pass
Machine learning for phenotypic drug discovery
AI in Drug Discovery and Development
William Godinez, Senior Principal Data Scientist, Novartis
Sep 1812:25
Conference pass
Digitalizing Pfizer Biologics R&D
Digital Transformation
Yuan Lin, Global Biologics Solution Lead, Pfizer
Sep 1812:25
Conference pass
Data Governance isn’t one size fits all
Data Integration + FAIR
Jennifer Lee Jennifer Lee, Senior Vice President, Novita Pharmaceuticals
Sep 1812:25
Conference pass
Deep Biology as a translational platform for immune-mediated diseases
Bioinformatics + In Silico R&D
Sep 1812:25
Conference pass
Exploiting UK and American collaboration opportunities for Real World Evidence Generation
Real World Evidence
Adrian Jonas, Chief Analyst for the North West Region, NHS England
Sep 1812:25
Conference pass
Gen AI powering Medical and Patient Safety reviews
Analytics Platform
Sep 1812:25
Conference pass
Quantum technologies for the life sciences
Quantum Integration
Warwick Bowen, Professor, The University of Queensland
Sep 1812:25
Conference pass
Cutting Edge -Omics Research and Early-stage Startups in Precision Medicine
Precision Medicine and Liquid Biopsy
Vaibhav Saini, Sr. Commercialization Manager, Northeastern University
Sep 1812:25
Conference pass
Speaker presentation
Rare Diseases in Genomics
Kathleen Barnes, Professor of Medicine & Epidemiology, University Of Colorado Anschutz Medical Campus
Sep 1813:05
Conference pass
Leveraging AI to enhance the clinical development decision making
AI in Drug Discovery and Development
Zhaoling Meng, AVP, Global Head Clinical Modeling & Evidence Integration, Data and Data Sciences, Sanofi
Sep 1813:05
Conference pass
Domain specific LLM development for enterprise: approaches and challenges
Large Language Models
Zhenwen Shao, Director of Head of Digital Product Development, Johnson & Johnson
Sep 1813:05
Conference pass
How Data Centric Approaches are Transforming the Commercialization Success in the Life Sciences Industry
Digital Transformation
Nuvan Dassanaike, SVP of Marketing and Digital Strategy, Accord Healthcare
Sep 1813:05
Conference pass
Integrated data management systems for driving faster insights for biomarker data
Data Integration + FAIR
Samir Wadhawan, Director Oncology Data Strategy, Analytics, TAKEDA
Sep 1813:05
Conference pass
Investigation of regulatory genes in a systems biology and machine learning perspective
Bioinformatics + In Silico R&D
Qi Song, Senior Scientist, Bristol Myers Squibb
Sep 1813:05
Conference pass
Clinical Decision Support Systems: Applying Data Science and Machine Learning in Service of Health Equity
Real World Evidence
Sep 1813:05
Conference pass
Development of analytics screens for versatile screening platforms
Analytics Platform
Pavan Patel, Senior Scientist, Interius BioTherapeutics, Inc.
Sep 1813:05
Conference pass
Investment framework on Quantum for drug discovery
Quantum Integration
Sep 1813:05
Conference pass
Advancement of digital innovation in autoimmune diseases
Precision Medicine and Liquid Biopsy
Jin Lee, Investor, Oxford angel fund
Sep 1813:05
Conference pass
Defining patient engagement in the age of patient-led drug discovery
Rare Diseases in Genomics
Sep 1814:25
Conference pass
Sep 1814:25
Conference pass
Chair remarks
Digital Transformation
Aslam Khan, Head of Product Management - R&D, Takeda Pharmaceuticals
Sep 1814:25
Conference pass
Chair remarks
Real World Evidence
Adrian Jonas, Chief Analyst for the North West Region, NHS England
Sep 1814:25
Conference pass
Chair remarks
Quantum Integration
Wolfgang Losert, Professor of Physics, University of Maryland
Sep 1814:25
Conference pass
Chair remarks
Precision Medicine and Liquid Biopsy
Paola Correa, Bioinformatics Specialist, Gilead Sciences
Sep 1814:25
Conference pass
Chair remarks
Rare Diseases in Genomics
Christina Waters, Chief Executive Officer, RARE Science
Sep 1814:30
Conference pass
AI and Digital platform technologies: Sustaining company growth
AI in Drug Discovery and Development
Sep 1814:30
Conference pass
Research focus for digital products in healthcare
Digital Transformation
Thomas Prangenberg, Head of Product and Design, Boehringer Ingelheim
Sep 1814:30
Conference pass
Federated trial emulations using real-world data for drug repositioning
Data Integration + FAIR
Yong Chen, Professor of Biostatistics, University of Pennsylvania
Sep 1814:30
Conference pass
Democratizing Target discovery and validation through personalized learning journeys
Bioinformatics + In Silico R&D
Breakthroughs in drug discovery depend on bioinformatics and in silico R&ED. Understanding the conclusions and harnessingthem in target discovery and validation rely on digital literacy, often overlooked yet pivotal. Our session will share insights, struggles, and solutions from our journey to create personalized learning journeys in bioinformatics and in silico R&ED within the line of business, integrating digital advancements into the everyday practice of R&ED, locally and globally. The goal is to prepare everyone for genAI employability, harvest digital skills to democratize understanding of bioinformatics and in silico R&ED within the line of business, and seamlessly integrate these practices within a global setting.
Søren Schandorff, Learning Officer, Novo Nordisk
Sep 1814:30
Conference pass
Using real world data to identify meaningful outcomes and endpoints
Real World Evidence
Sep 1814:30
Conference pass
Utility of analytics platforms
Analytics Platform
Thomas Dougherty, Data Science & AI Innovative Partnership Lead, Novo Nordisk
Sep 1814:30
Conference pass
Nanocluster Bioactuators, Quantum sensing and actuation
Quantum Integration
Wolfgang Losert, Professor of Physics, University of Maryland
Sep 1814:30
Conference pass
Precision medicine collaboration in the liquid biopsy space: challenges and opportunities
Precision Medicine and Liquid Biopsy
Nicole StJean, Head of Precision Medicine, External Business Strategy, GSK
Sep 1814:30
Conference pass
Redefining regulatory pathways in rare disease with patient advocates
Rare Diseases in Genomics
Mary Leuchars, Senior Director of Rare Disease, Moderna, Inc.
Sep 1814:50
Conference pass
Challenges and solutions of patient engagement in N of 1 trials
Rare Diseases in Genomics
Neena Nizar, President and Founder, The Jansens Foundation
Sep 1815:10
Conference pass
Generative AI models for drug discovery
AI in Drug Discovery and Development
Sep 1815:10
Conference pass
Precision medicine in identifying rare diseases in clinical trials
Large Language Models
Guglielmo Iozzia, Associate Director - Machine Learning and AI, MSD
Sep 1815:10
Conference pass
Digital Patient Monitoring
Digital Transformation
Christina Kotsi, Digital Lead, Global Medical Affairs, Bayer
Sep 1815:10
Conference pass
A multi-disciplinary approach at SPARC: igniting multi-disciplinary trail blaze for AI enabled drug discovery.
Bioinformatics + In Silico R&D
Jake Chen, Professor and Chief Bioinformatics Officer, University of Alabama at Birmingham
Sep 1815:10
Conference pass
Bridging the health disparity gap with Diverse and Inclusive data collection in clinical trials
Real World Evidence
Donna Sattler, Director, Clinical Data Standards, Bristol Myers Squibb
Sep 1815:10
Conference pass
Developing skills and competencies for modern day analytics for healthcare
Analytics Platform
Veena Swaminathan, Head of Portfolio Analytics - Global R&D, Sanofi
Sep 1815:10
Conference pass
Necrobotics 360: Shaping the Future of Healthcare
Quantum Integration
Revolutionizing patient care: Necrobotics pioneers a healthcare revolution by seamlessly integrating AI and robotics, pushing the boundaries of innovation in patient treatment and diagnostics.
Precision in healthcare procedures: Exploring the dynamic synergy between AI and robotics, enhancing precision in diagnostics, surgeries and overall healthcare delivery for a more effective patient experience.
Navigating ethical considerations: Delving into the ethical considerations surrounding AI-driven necrobotics, emphasizing responsible deployment through the establishment of robust regulatory frameworks.
Collective vision for tomorrow: Necrobotics serves as a collaborative platform, bringing together experts and stakeholders to shape a future where AI and robotics harmonize to redefine and elevate the healthcare landscape.
Sep 1815:10
Conference pass
AI Driven Precision Medicine
Precision Medicine and Liquid Biopsy
Shameer Khader, Global Head, Data Science and Precision Medicine, Sanofi
Sep 1815:10
Conference pass
Revolutionizing Healthcare: Unleashing Innovation in Academic Institution
Rare Diseases in Genomics
Sohela Shah, Program Director, Catalyst Program and Invent Fund, UCSF Innovation Venture
Sep 1815:30
Conference pass
Real World Evidence in Biosimilar Clinical Development
Real World Evidence
Liyi Cen, Group Head of Biostatistics, Sandoz
Sep 1815:30
Conference pass
Precision genetic therapies for rare diseases
Rare Diseases in Genomics
Nick Lench, Executive Director, Nucleic Acid Therapy Accelerator (NATA)
Sep 1815:50
Conference pass
Harnessing the Power of Generative AI: Unlocking Insights from Real-World Data for Data-Driven Decisions in Pharma R&D
AI in Drug Discovery and Development
Sep 1815:50
Conference pass
Generative AI: Five stages of grief
Large Language Models
Marco Andre, Global Head of Marketing Excellence, Novartis
Sep 1815:50
Conference pass
How to navigate volatility within your digital journey
Digital Transformation
Sudheer Elapavuluru, Principal Agile Coach - Global R&D and Development Strategies, Boehringer Ingelheim
Sep 1815:50
Conference pass
Multi-omics
Bioinformatics + In Silico R&D
Gaurav Kumar, Associate Director, Genomics and Computational Biology, Teva Pharmaceuticals
Sep 1815:50
Conference pass
Communicating to Senior Execs and Impacting Strategy to Drive Key Business Decisions
Real World Evidence
Alexa DeVita, Associate Director of Competitive Intelligence and Strategy, Vir Biotechnology, Inc.
Sep 1815:50
Conference pass
AI-powered clinical decision support system for heart surgery patients
Precision Medicine and Liquid Biopsy
Sep 1815:50
Conference pass
HNRNPs - An Emerging Class of Rare Neurodevelopmental Disorders
Rare Diseases in Genomics
Christopher Ricupero, Associate Research Scientist, Columbia University Irving Medical Center
Sep 1816:40
Conference pass
Chair remarks
AI in Drug Discovery and Development
Xiaoying Wu, VP, Data Science Solutions, Privacy & Ethics, R&D, Johnson & Johnson Innovation
Sep 1816:40
Conference pass
Sep 1816:40
Conference pass
Chair remarks
Digital Transformation
Aslam Khan, Head of Product Management - R&D, Takeda Pharmaceuticals
Sep 1816:40
Conference pass
Chair remarks
Real World Evidence
Adrian Jonas, Chief Analyst for the North West Region, NHS England
Sep 1816:40
Conference pass
Chair remarks
Analytics Platform
Sep 1816:40
Conference pass
Sep 1816:40
Conference pass
Chair remarks
Rare Diseases in Genomics
Anna Capria, Outreach Coordinator and Bioinformatic Analyst, J. Craig Venter Institute
Sep 1816:45
Conference pass
Using AI to optimize multiple properties of antibodies
AI in Drug Discovery and Development
Tzvika Hartman, SVP Computation, Biolojic Design
Sep 1816:45
Conference pass
Shaping the regulatory function to support product digital transformation
Digital Transformation
David Morra, Director, Regulatory Digital Health, Merck
Sep 1816:45
Conference pass
Harnessing the muscarinic system: from bench side to clinic
Bioinformatics + In Silico R&D
Samantha Yohn, Associate Director, Global Scientific communications, engagement and outreach, Karuna Therapeutics
Sep 1816:45
Conference pass
Developing the next BioTech Workforce: The impact of Belonging in K-12 STEM Education as a Tool to Gain and Sustain Interest in STEM
Real World Evidence
Ashley huderson, STEM and CS Equity Advisor, U.S. Department of Education
Sep 1816:45
Conference pass
Liquid Biopsy in solid tumours – are we there yet
Precision Medicine and Liquid Biopsy
Raluca Predoiu, Companion Diagnostic Strategy Lead, Abbvie
Sep 1816:45
Conference pass
Rare disease advocacy
Rare Diseases in Genomics
Anna Capria, Outreach Coordinator and Bioinformatic Analyst, J. Craig Venter Institute
Sep 1817:05
Conference pass
Closing keynote Panel
Keynotes
Moderator: Christina Waters, Chief Executive Officer, RARE Science
Victoria Gamerman, Head of Digital Transformation Center of Excellence, Boehringer Ingelheim
Sarah Odeh, National President, Women In Bio
Michele Colucci, Founder, Chief Executive Officer, Digital DX Ventures
last published: 23/Apr/24 15:25 GMT
Get involved at BioTechX USA
TO SPONSOR
Myra Christodoulou
myra.christodoulou@terrapinn.com
Joshua Kennedy
joshua.kennedy@terrapinn.com
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events